✦ LIBER ✦

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

✍ Scribed by Jeffrey L Lennox; Edwin DeJesus; Adriano Lazzarin; Richard B Pollard; Jose Valdez Ramalho Madruga; Daniel S Berger; Jing Zhao; Xia Xu; Angela Williams-Diaz; Anthony J Rodgers; Richard JO Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Peter Sklar

Book ID: 117304903
Publisher: The Lancet
Year: 2009
Tongue: English
Weight: 248 KB
Volume: 374
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)60918-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rilpivirine versus efavirenz with tenofo

Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

✍ Jean-Michel Molina; Pedro Cahn; Beatriz Grinsztejn; Adriano Lazzarin; Anthony Mi 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 210 KB

Switch to a raltegravir-based regimen ve

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

✍ Joseph J Eron; Benjamin Young; David A Cooper; Michael Youle; Edwin DeJesus; Jai 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 149 KB

Safety and efficacy of zinc supplementat

Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial

✍ Raziya Bobat; Hoosen Coovadia; Cindy Stephen; Kimesh L Naidoo; Neil McKerrow; Ro 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 89 KB

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ José Valdez Madruga; Pedro Cahn; Beatriz Grinsztejn; Richard Haubrich; Jacob Lal 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Safety and efficacy of the HIV-1 integra

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

✍ Beatriz Grinsztejn; Bach-Yen Nguyen; Christine Katlama; Jose M Gatell; Adriano L 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 179 KB

Efficacy and safety of TMC125 (etravirin

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

✍ Adriano Lazzarin; Thomas Campbell; Bonaventura Clotet; Margaret Johnson; Christi 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB